Literature DB >> 24917971

Hedgehog inhibition reduces angiogenesis by downregulation of tumoral VEGF-A expression in hepatocellular carcinoma.

Matthias Pinter1, Wolfgang Sieghart1, Monika Schmid1, Bernhard Dauser2, Gerald Prager1, Hans Peter Dienes1, Michael Trauner1, Markus Peck-Radosavljevic1.   

Abstract

BACKGROUND: Dysregulation and activation of Hedgehog (Hh) signalling may contribute to tumorigenesis, angiogenesis, and metastatic seeding in several solid tumours.
OBJECTIVE: We investigated the impact of Hh inhibition on tumour growth and angiogenesis using in-vitro and in-vivo models of hepatocellular carcinoma (HCC).
METHODS: The effect of the Hh pathway inhibitor GDC-0449 on tumour growth was investigated using an orthotopic rat model. Effects on angiogenesis were determined by immunohistochemical staining of von Willebrand factor antigen and by assessing the mRNA expression of several angiogenic factors. In vitro, HCC cell lines were treated with GDC-0449 and evaluated for viability and expression of vascular endothelial growth factor (VEGF). Endothelial cells were evaluated for viability, migration, and tube formation.
RESULTS: In the orthotopic HCC model, GDC-0449 significantly decreased tumoral VEGF expression which was accompanied by a significant reduction of microvessel density and tumour growth. In HCC cells, GDC-0449 had no effect on cell growth but significantly reduced target gene regulation and VEGF expression while having no direct effect on endothelial cell viability, migration, and tube formation.
CONCLUSIONS: Hh inhibition with GDC-0449 downregulates tumoral VEGF production in vitro and reduces tumoral VEGF expression, angiogenesis, and tumour growth in an orthotopic HCC model.

Entities:  

Keywords:  Angiogenesis; GDC-0449; VEGF; hedgehog; hepatocellular carcinoma

Year:  2013        PMID: 24917971      PMCID: PMC4040790          DOI: 10.1177/2050640613496605

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN: 2050-6406            Impact factor:   4.623


  54 in total

Review 1.  Hedgehog signaling in the liver.

Authors:  Alessia Omenetti; Steve Choi; Gregory Michelotti; Anna Mae Diehl
Journal:  J Hepatol       Date:  2010-10-14       Impact factor: 25.083

2.  Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus.

Authors:  J Zhou; Z Y Tang; J Fan; Z Q Wu; X M Li; Y K Liu; F Liu; H C Sun; S L Ye
Journal:  J Cancer Res Clin Oncol       Date:  2000-01       Impact factor: 4.553

3.  Clinical characteristics of patients with hepatocellular carcinoma in Austria - is there a need for a structured screening program?

Authors:  Florian Hucke; Wolfgang Sieghart; Maximilian Schöniger-Hekele; Markus Peck-Radosavljevic; Christian Müller
Journal:  Wien Klin Wochenschr       Date:  2011-07-29       Impact factor: 1.704

4.  Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors.

Authors:  Patricia M LoRusso; Charles M Rudin; Josina C Reddy; Raoul Tibes; Glen J Weiss; Mitesh J Borad; Christine L Hann; Julie R Brahmer; Ilsung Chang; Walter C Darbonne; Richard A Graham; Kenn L Zerivitz; Jennifer A Low; Daniel D Von Hoff
Journal:  Clin Cancer Res       Date:  2011-02-07       Impact factor: 12.531

5.  Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors.

Authors:  Oriol Casanovas; Daniel J Hicklin; Gabriele Bergers; Douglas Hanahan
Journal:  Cancer Cell       Date:  2005-10       Impact factor: 31.743

Review 6.  Hepatocellular carcinoma.

Authors:  Alejandro Forner; Josep M Llovet; Jordi Bruix
Journal:  Lancet       Date:  2012-02-20       Impact factor: 79.321

7.  Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma.

Authors:  Abby B Siegel; Emil I Cohen; Allyson Ocean; Deborah Lehrer; Alec Goldenberg; Jennifer J Knox; Helen Chen; Sean Clark-Garvey; Alan Weinberg; John Mandeli; Paul Christos; Madhu Mazumdar; Elizabeta Popa; Robert S Brown; Shahin Rafii; Jonathan D Schwartz
Journal:  J Clin Oncol       Date:  2008-06-20       Impact factor: 44.544

8.  Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.

Authors:  Matthias Lauth; Asa Bergström; Takashi Shimokawa; Rune Toftgård
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-09       Impact factor: 11.205

Review 9.  The adventures of sonic hedgehog in development and repair. II. Sonic hedgehog and liver development, inflammation, and cancer.

Authors:  Alessia Omenetti; Anna Mae Diehl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-01-24       Impact factor: 4.052

10.  Microparticles harboring Sonic Hedgehog promote angiogenesis through the upregulation of adhesion proteins and proangiogenic factors.

Authors:  Raffaella Soleti; Tarek Benameur; Chiara Porro; Maria Antonietta Panaro; Ramaroson Andriantsitohaina; Maria Carmen Martínez
Journal:  Carcinogenesis       Date:  2009-01-23       Impact factor: 4.944

View more
  13 in total

1.  BRD4 induces cell migration and invasion in HCC cells through MMP-2 and MMP-9 activation mediated by the Sonic hedgehog signaling pathway.

Authors:  Yong-Hui Wang; Xiao-Mei Sui; Ya-Na Sui; Qin-Wei Zhu; Kai Yan; Li-Shan Wang; Fei Wang; Jia-Hua Zhou
Journal:  Oncol Lett       Date:  2015-08-04       Impact factor: 2.967

Review 2.  The hedgehog pathway in nonalcoholic fatty liver disease.

Authors:  Mariana Verdelho Machado; Anna Mae Diehl
Journal:  Crit Rev Biochem Mol Biol       Date:  2018-03-20       Impact factor: 8.250

Review 3.  Hedgehog signalling in liver pathophysiology.

Authors:  Mariana Verdelho Machado; Anna Mae Diehl
Journal:  J Hepatol       Date:  2017-10-26       Impact factor: 25.083

4.  Macrophages and endothelial cells orchestrate tumor-associated angiogenesis in oral cancer via hedgehog pathway activation.

Authors:  Ludmila de Faro Valverde; Thiago de Almeida Pereira; Rosane Borges Dias; Vanessa Sousa Nazaré Guimarães; Eduardo Antônio Gonçalves Ramos; Jean Nunes Santos; Clarissa Araújo Gurgel Rocha
Journal:  Tumour Biol       Date:  2016-01-15

5.  Intravenous Administration Is an Effective and Safe Route for Cancer Gene Therapy Using the Bifidobacterium-Mediated Recombinant HSV-1 Thymidine Kinase and Ganciclovir.

Authors:  Huicong Zhou; Zhiliang He; Changdong Wang; Tingting Xie; Lin Liu; Chuanyang Liu; Fangzhou Song; Yongping Ma
Journal:  Int J Mol Sci       Date:  2016-06-06       Impact factor: 5.923

Review 6.  Hedgehog signaling: modulation of cancer properies and tumor mircroenvironment.

Authors:  Ann Hanna; Lalita A Shevde
Journal:  Mol Cancer       Date:  2016-03-18       Impact factor: 27.401

Review 7.  Implication of the Hedgehog pathway in hepatocellular carcinoma.

Authors:  Carminia Maria Della Corte; Giuseppe Viscardi; Federica Papaccio; Giovanna Esposito; Giulia Martini; Davide Ciardiello; Erika Martinelli; Fortunato Ciardiello; Floriana Morgillo
Journal:  World J Gastroenterol       Date:  2017-06-28       Impact factor: 5.742

8.  Bcl-2 degradation is an additional pro-apoptotic effect of polo-like kinase inhibition in cholangiocarcinoma cells.

Authors:  Svenja Sydor; Sami Jafoui; Lena Wingerter; Sandra Swoboda; Joachim C Mertens; Guido Gerken; Ali Canbay; Andreas Paul; Christian D Fingas
Journal:  World J Gastroenterol       Date:  2017-06-14       Impact factor: 5.742

9.  Statins activate the canonical hedgehog-signaling and aggravate non-cirrhotic portal hypertension, but inhibit the non-canonical hedgehog signaling and cirrhotic portal hypertension.

Authors:  Frank E Uschner; Ganesh Ranabhat; Steve S Choi; Michaela Granzow; Sabine Klein; Robert Schierwagen; Esther Raskopf; Sebastian Gautsch; Peter F M van der Ven; Dieter O Fürst; Christian P Strassburg; Tilman Sauerbruch; Anna Mae Diehl; Jonel Trebicka
Journal:  Sci Rep       Date:  2015-09-28       Impact factor: 4.379

10.  Expression and significance of the Hedgehog signal transduction pathway in oxygen-induced retinal neovascularization in mice.

Authors:  Meilin Liu; Xiaolong Chen; Henan Liu; Yu Di
Journal:  Drug Des Devel Ther       Date:  2018-05-21       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.